79368658

Information

• Trademark
• 79368658

• Source

• Serial Number

  79368658

• Registration Number

  7324629

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  December 13, 2022
  3 years ago

• Registration Date

  March 12, 2024
  a year ago

• Transaction Date

  February 08, 2025
  11 months ago

• Status Date

  March 12, 2024
  a year ago

• Published for Opposition Date

  December 26, 2023
  2 years ago

• Location Date

  March 12, 2024
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BULLOFF, TOBY

• Attorney Docket Number

  04671053

  Attorney Name

  Patricia A Wilczynski Brozek

  Law Office Assigned Location Code

  N10

• Owners

  • CYTOGEN CO., LTD.

Case File Statements

• DM0000: The mark consists of a water drop in white contained inside of a hexagon with mixed blue and red.
• GS0051: Diagnostic reagents for immunization against disease; diagnostic test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; biological and chemical reagents for medical or veterinary purposes; diagnostic test reagents for medical or veterinary purposes; biological preparations for medical or veterinary purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; biochemical preparations for medical or veterinary purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; biological reagents for medical purposes; biological preparations for medical purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic chemical reagents for medical use; chemical preparations for testing blood for medical purposes; reagents for blood grouping for medical purposes; reactants for medical diagnosis; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; antibodies for medical purposes; blood components for medical purposes; pharmaceutical preparations for use in hematology
• CC0000: The color(s) white, blue and red is/are claimed as a feature of the mark.
• GS0011: Reagents for scientific or medical research use; biological preparations for scientific or laboratory purposes; diagnostic preparations for scientific or research use; diagnostic reagents for scientific use; diagnostic preparations for scientific use; antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; chemical reagents for scientific purposes; biological preparations for use in biotechnology other than medical use; reagents for cell transformation other than for medical or veterinary use; reagents for research purposes; chemical reagents for use in genetic research; reagents for medical research; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; reagents for chemical analyses; chemical reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis
• GS0441: Medical and healthcare services relating to DNA, genetics and genetic testing; health care; physical examination services; medical analysis services for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment; genetic testing for medical purposes; DNA analysis for medical purposes; DNA screening for medical purposes; medical testing for diagnostic or treatment purposes; medical laboratory services for the analysis of blood samples; medical laboratory services for the analysis of blood samples taken from patients
• GS0101: Home virus test kits comprised primarily of medical diagnostic apparatus for testing for viruses, test strips and reagents; medical measuring instruments for cancer diagnosis; apparatus for the diagnosis of inflammatory diseases; genetic testing apparatus for medical purposes; genetic verification apparatus for medical purposes; apparatus for DNA and RNA testing for medical purposes; immunofluorescence analysis apparatus for medical purposes; cell testing apparatus for medical purposes; medical genetic analyzer; apparatus for carrying-out diagnostic tests for medical purposes, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; medical diagnostic apparatus and instruments, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic apparatus for medical purposes, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; ultrasonic diagnostic instruments for medical use; medical blood heaters; blood analysis apparatus for diagnosis; blood warmers; blood testing apparatus; apparatus for blood analysis; blood filters
• GS0421: Genetic testing for scientific research purposes; DNA analysis for scientific research purposes; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of pharmacy; research in the field of gene analysis; scientific research in the field of genetics and genetic engineering; medical laboratories; scientific research in the field of biomedicine; analysis and evaluation of medical product development; blood testing for medical research; clinical research in the field of oncology, genetics, viral diseases, carcinoid tumors, pharmaceutical cancer treatment, lymphatic cancer, liquid biopsy, drug efficiency and drug resistance; blood analysis services; blood analysis services for scientific research purposes

Case File Event Statements

• 9/18/2023 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/4/2023 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 5/5/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/9/2023 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/20/2023 - 2 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 9/19/2023 - 2 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/2/2023 - 2 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 10/2/2023 - 2 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 10/25/2023 - 2 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 11/16/2023 - 2 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/16/2023 - 2 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/17/2023 - 2 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/20/2023 - 2 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/27/2023 - 2 years ago

  15 - CORRECTION SENT TO IB Type: CRSN

• 11/27/2023 - 2 years ago

  14 - CORRECTION CREATED FOR IB Type: CRCR

• 12/6/2023 - 2 years ago

  18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 12/6/2023 - 2 years ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/6/2023 - 2 years ago

  17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 12/26/2023 - 2 years ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/26/2023 - 2 years ago

  20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/12/2024 - a year ago

  22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/2/2024 - 2 years ago

  21 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 6/13/2024 - a year ago

  24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 7/21/2024 - a year ago

  26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 3/12/2024 - a year ago

  23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 7/21/2024 - a year ago

  25 - FINAL DISPOSITION PROCESSED Type: FIMP

• 2/7/2025 - 11 months ago

  28 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 8/11/2024 - a year ago

  27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO